| XABM01 | 6-Bromo-4-Fluoro-1-Isopropyl-2-Methyl-1H-Benzo[d]Imidazole | 1231930-33-8 | Abemaciclib |
| XABM02 | 2,4-Dichloro-5-Fluoropyrimidine | 2927-71-1 | Abemaciclib |
| XACA01 | (4-(Pyridin-2-Ylcarbamoyl)Phenyl)Boronic Acid | 850568-25-1 | Acalabrutinib |
| XACA02 | N-2-Pyridinyl-4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-yl)Benzamide | 1383385-64-5 | Acalabrutinib |
| XACA03 | (S)-Benzyl 2-(8-Amino-1-Bromoimidazo[1,5-a]Pyrazin-3-yl)Pyrrolidine-1-Carboxylate | 1420478-88-1 | Acalabrutinib |
| XAPA01 | 4-Amino-2-Fluoro-N-Menthylbenzamide | 915087-25-1 | Apalutamide |
| XAPA02 | 5-Amino-3-(Trifluoromethyl)2-Cyanopyridine | 573762-62-6 | Apalutamide |
| XAPI01 | 3,3-Dichloro-1-(4-Nitrophenyl)-2-Piperidinone | 881386-01-2 | Apixaban |
| XAPI02 | 5,6-Dihydro-3-(4-Morpholinyl)-1-[4-(2-Oxo-1-Piperidinyl)Phenyl]-2(1H)-Pyridinone | 545445-44-1 | Apixaban |
| XAPI04 | 1-(4-Aminophenyl)-5,6-Dihydro-3-(4-Morpholinyl)-2(1H)-Pyridinone | 1267610-26-3 | Apixaban |
| XAPI05 | 2-Chloro-2-[2-(4-Methoxyphenyl)Hydrazinylidene]Acetic Acid, Ethyl Ester | 27143-07-3 | Apixaban |
| XAPI07 | 4,5,6,7-Tetrahydro-1-(4-Methoxyphenyl)-7-Oxo-6-[4-(2-Oxo-1-Piperidinyl)Phenyl]-1H-Pyrazolo[3,4-c]Pyridine-3-Carboxylic Acid, Ethyl Ester | 503614-91-3 | Apixaban |
| XATO01 | 1-(Tert-Butyl)-3-((5-Chloro-3-(Chloromethyl)Pyridin-2-yl)Methyl)-1,3-Dihydro-2H-Pyrrolo[2,3-b]Pyridin-2-One | 1455358-12-9 | Atogepant |
| XATO02 | (S)-1'-(Tert-Butyl)-2'-Oxo-1',2',5,7-Tetrahydrospiro[Cyclopenta[B]Pyridine-6,3'-Pyrrolo[2,3-B]Pyridine]-3-Carboxylic Acid | 1455358-16-3 | Atogepant |
| XATO03 | Ubrogepant Intermediate | 1375541-21-1 | Atogepant |
| XATO04 | (2-Bromo-5-Chloropyridin-3-yl)Methanol | 1227585-65-0 | Atogepant |
| XATO05 | 1-(Tert-butyl)-1,3-Dihydro-2H-Pyrrolo[2,3-B]Pyridin-2-One | 1455358-06-1 | Atogepant |
| XATO06 | 1-(2,3,6-Trifluorophenyl)Propan-2-One | 1305324-34-8 | Atogepant |
| XATO07 | N-Tert-Butyl-L-Serineisopropyl Ester | 955379-18-7 | Atogepant |
| XAVA01 | 4-(4-Chloro-2-Thienyl)-2-Thiazolamine | 570407-10-2 | Avatrombopag |
| XAVI01 | (2S,5S)-5-Hydroxy-Piperidine-1,2-Dicarboxylic Acid 1-Tert-butyl Ester | 1487347-86-3 | Avibactam |
| XAVI02 | Trans-6-Benzyloxy-7-Oxo-1,6-Diazabicyclo[3.2.1]Octane-2-Carboxylic Acid | 1174020-25-7 | Avibactam |
| XBAI02 | 4-(1H-Pyrazol-4-yl)-7-((2-(Trimethylsilyl)Ethoxy)Methyl-7H-Pyrrolo[2,3-d]Pyrimidine | 941685-27-4 | Baricitinib |
| XBAI03 | 2-(1-(Ethylsulfonyl)Azetidin-3-Ylidene)Acetonitrile | 1187595-85-2 | Baricitinib |
| XBAI04 | Tert-Butyl 3-(Cyanomethylene)Azetidine-1-Carboxylate | 1153949-11-1 | Baricitinib |
| XBAI05 | 1-(1-Ethoxyethyl)-4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-yl)-1H-Pyrazole | 1029716-44-6 | Baricitinib |
| XBRI01 | (R)-Dihydro-4-Propyl-2(3H)-Furanone | 63095-51-2 | Brivaracetam |
| XBRI02 | (R)-N-((S)-1-Amino-1-Oxobutan-2-yl)-3-(Chloromethyl) Hexanamide | 2052297-74-0 | Brivaracetam |
| XBUM01 | 4-Chloro-3-Nitro-5-Sulphamoylbenzoic Acid | 22892-96-2 | Bumetanide |
| XCAT01 | (2R)-3-Acetylthio-2-Methylpropionyl Chloride | 74345-73-6 | Captopril |
| XCAP01 | (D-3-Acetylthio-2-methylpropanoic acid) | 76497-39-7 | Captopril |
| XCRI01 | 2-Bromo-5-Hydroxybenzadehyde | 2973-80-0 | Crisaborole |
| XCRI04 | 4-(4-Bromo-3-Formylphenoxy)Benzonitrile | 906673-54-9 | Crisaborole |
| XCRI05 | 4-(4-Bromo-3-(Hydroxymethyl)Phenoxy)Benzonitrile | 906673-45-8 | Crisaborole |
| XDAP01 | Ethyl Isocyanatoacetate | 2949-22-6 | Daprodustat |
| XDEU01 | 4,6-Dichloro-N-Trideuteromethylpyridazine-3 -Carboxamide | 1609393-89-6 | Deucravacitinib |
| XDEL01 | 4-[4-[4-(Trifluoromethoxy)Phenoxy]Piperidin-1-yl]Phenol | 681482-81-5 | Delamanid |
| XDEL02 | (R)-2-Methyl-6-Nitro-2-((4-(4-(4-(Trifluoromethoxy)Phenoxy)Piperidin-1-yl)Phenoxy)Methyl)-2,3-Dihydroimidazo[2,1-b]Oxazole | 681492-22-8 | Delamanid |
| XDUL01 | (S)-3-(Methylamino)-1-(2-Thienyl)-1-Propanol | 116539-55-0 | Duloxetine |
| XEDO01 | Tert-Butyl[(1R,2S,5S)-2-Amino-5-[(Dimethylamino)Carbonyl]Cyclohexyl]Carbamate Oxalate | 1210348-34-7 | Edoxaban Tosylate Hydrate |
| XEDO02 | 2-[(5-Chloropyridin-2-yl)Amino]-2-Oxoacetic Acid Ethyl Ester Monohydrochloride | 1243308-37-3 | Edoxaban Tosylate Hydrate |
| XEDO03 | 5-Methyl-4,5,6,7-Tetrahydrothiazolo[5,4-c]Pyridine-2-Carboxylic Acid Hydrochloride | 720720-96-7 | Edoxaban Tosylate Hydrate |
| XEDO05 | N-[(1R,2S,5S)-2-Amino-5-[(Dimethylamino)Carbonyl]Cyclohexyl]Carbamic Acid 1,1-Dimethylethyl Ester Ethanedioate Hydrate (1:1:1) | 1353893-22-7 | Edoxaban Tosylate Hydrate |
| XEDO06 | 2-[(5-Chloropyridin-2-yl)-Amino]-2-Oxoacetate Ethyl Ester | 349125-08-2 | Edoxaban Tosylate Hydrate |
| XEDO07 | N-[(1R,2S,5S)-2-Amino-5-[(Dimethylamino)Carbonyl]Cyclohexyl]-Carbamic Acid, 1,1-Dimethylethyl Ester | 365998-36-3 | Edoxaban Tosylate Hydrate |
| XELC01 | 7-(Benzyloxy)-3-BroMo-1,2-Dihydronaphthalene | 722536-73-4 | Elacestrant |
| XELC02 | 2'-Bromo-5'-methoxyacetanilide | 123027-99-6 | Elacestrant |
| XELC03 | N-Ethyl-2-(4-Formylphenyl)Acetamide | 2477812-42-1 | Elacestrant |
| XELA02 | 2-Fluoro-3-Methoxyphenylboronic Acid | 352303-67-4 | Elagolix sodium |
| XELA05 | 5-Bromo-1-[[2-Fluoro-6-(Trifluoromethyl)Phenyl]Methyl]-6-Methyl-2,4(1H,3H)-Pyrimidinedione | 830346-48-0 | Elagolix sodium |
| XELA06 | 5-(2-Fluoro-3-Methoxyphenyl)-1-(2-Fluoro-6-(Trifluoromethyl)Benzyl)-6-Methylpyrimidine-2,4(1H,3H)-Dione | 1150560-59-0 | Elagolix sodium |
| XFLU01 | 2-AMino-N-(2,2,2-Trifluoroethyl)Acetamide Hydrochloride | 1171331-39-7 | Fluralaner |
| XGAD01 | 4,4-Dimethyl-3,5,8-Trioxabic-Yclo[5,1,0]Octane | 57280-22-5 | Gadobutrol |
| XGAD02 | (+/-)-5-Benzoyl-2,3-Dihydro-1H-Pyrrolizine-1-Carboxylic Acid Tris(Hydroxymethyl)Methylamine Salt | 74103-07-4 | Gadobutrol |
| XGAD03 | 1,4,7,10-Tetraazacyclododecane (Cyclen) Tetrahydrochloride | 10045-25-7 | Gadobutrol |
| XISA01 | (2R,3R)-3-(2,5-Difluorophenyl)-3-Hydroxy-2-Methyl-4-(1H-1,2,4-Triazol-1-yl)Thiobutyramide | 368421-58-3 | Isavuconazole |
| XLAS01 | 2,4,6-Trifluorobenzoic Acid | 28314-80-9 | Lasmiditan |
| XLUM01 | 4-Chloro-4'-Fluorobutyrophenone | 3874-54-2 | Lumateperone |
| XLUM02 | (4aS,9bR)-6-Bromo-2,3,4,4a,5,9b-Hexahydro-1H-Pyrido[4,3-b]Indole | 1059630-07-7 | Lumateperone |
| XLUM03 | (4aS,9bR)-Ethyl 6-Bromo-5-(2-(Methylamino)-2-Oxoethyl)-3,4,4a,5-Tetrahydro-1H-Pyrido[4,3-b]Indole-2(9bH)-Carboxylate | 2098497-32-4 | Lumateperone |
| XMIN01 | 4,5-Dichlorobenzene-1,2-Diamine | 5348-42-5 | Maribavir |
| XMIN02 | 4-Chloro-2,6-Diaminopyrimidine | 156-83-2 | Minoxidil |
| XORB02 | 2,4-Dichloro-3-Cyano-5-Fluorobenzoic Acid | 117528-58-2 | Orbifloxacin |
| XOSE01 | (1S,5R,6S)-Ethyl 5-(Pentan-3-yl-Oxy)-7-Oxa-Bicyclo[4.1.0]hept-3-Ene-3-Arboxylate | 204254-96-6 | Oseltamivir |
| XOSE02 | Shikimic Acid | 138-59-0 | Oseltamivir |
| XPAL01 | Tert-Butyl 4-(6-Aminopyridin-3-yl)Piperazine-1-Carboxylate | 571188-59-5 | Palbociclib |
| XPAL02 | 2-Chloro-8-Cyclopentyl-5-Methylpyrido[2,3-d]Pyrimidin-7(8H)-One | 1013916-37-4 | Palbociclib |
| XPAI01 | 3-(2-Chloroethyl)-2-Methyl-9-Hydroxy-4H-Pyrido[1,2-a]Pyrimidin-4-One | 260273-82-3 | Paliperidone |
| XPON01 | 3-Bromoimidazo[1,2-b]Pyridazine | 18087-73-5 | Ponatinib |
| XPON02 | 1-Methyl-4-{[4-Nitro-2-(Trifluoromethyl)Phenyl]Methyl}Piperazine | 694499-24-6 | Ponatinib |
| XPON03 | 4-[(4-Methylpiperazin-1-yl)Methyl]-3-(Trifluoromethyl)Aniline | 694499-26-8 | Ponatinib |
| XPON04 | 3-Ethynylimidazolo[1,2-B]Pyridazine | 943320-61-4 | Ponatinib |
| XREL01 | Ethyl 2-((2,6-Difluorobenzyl)(Ethoxycarbonyl)Amino)-4-Methyl-5-(4-Nitrophenyl)Thiophene-3-Carboxylate | 308831-94-9 | Relugolix |
| XREL02 | 3-Amino-6-Methoxypyridazine | 7252-84-8 | Relugolix |
| XRIM01 | 1-Piperidinecarboxylic Acid, 4-[(2-Amino-3-Pyridinyl)Amino]-, 1,1-Dimethylethyl Ester | 781649-86-3 | Rimegepant |
| XRIM02 | (6S,9R)-6-(2,3-Difluorophenyl)-6,7,8,9-Tetrahydro-9-[[Tris(1-Methylethyl)Silyl]oxy]-5H-Cyclohepta[b]Pyridin-5-One | 1190363-46-2 | Rimegepant |
| XRIM03 | (5S,6S,9R)-5-Amino-6-(2,3-Difluorophenyl)-6,7,8,9-Tetrahydro-5H-Cyclohepta[C]Pyridin-9-ol:Dihydrochloride | 1373116-07-4 | Rimegepant |
| XRIM05 | Rimegepant Sulfate | 1374024-48-2 | Rimegepant |
| XRIT01 | Benzyl(2S,5R)-5-Amino-2-Methylpiperidine-1-Carboxylate | 1207853-23-3 | Ritlecitinib |
| XROP01 | Ethyl 5-Chloropyrazolo[1,5-A]Pyrimidine-3-Carboxylate | 1224944-77-7 | Ropotrectinib |
| XROX01 | 4-Hydroxy-7-Phenoxyisoquinoline-3-Carboxylic Acid Methyl Ester | 1455091-10-7 | Roxadustat |
| XROX02 | Methyl 4-Hydroxy-1-Methyl-7-Phenoxyisoquinoline-3-Carboxylate | 1421312-34-6 | Roxadustat |
| XTOF01 | 2-(Trimethylsilyl)Ethoxymethyl Chloride | 76513-69-4 | Tofacitinib Citrate |
| XRUX05 | 3-Cyclopentylacrylonitrile | 591769-05-0 | Ruxolitinib Phosphate |
| XRUX06 | Pyrazole-4-Boronic Acid Pinacol Ester | 269410-08-4 | Ruxolitinib Phosphate |
| XRUX07 | 4-Chloro-7-((2-(Trimethylsilyl)Ethoxy)Methyl)-7H-Pyrrolo[2,3-d]Pyrimidine | 941685-26-3 | Ruxolitinib Phosphate |
| XRUX09 | Pyrrolo[2,3-d]Pyrimidin-4-Ol | 3680-71-5 | Ruxolitinib Phosphate |
| XTOF04 | 4-Chloropyrrolo[2,3-d]Pyrimidine | 3680-69-1 | Tofacitinib Citrate |
| XSIL01 | (R)-3-(5-(2-Aminopropyl)-7-Cyanoindolin-1-yl)Propyl Benzoate (2R,3R)-2,3-Dihydroxysuccinate | 239463-85-5 | Silodosin |
| XSPA01 | 4-Bromo-3-Ethoxymethyl-Benzoic Acid Ethyl Ester | 948349-66-4 | Sparsentan |
| XSPA02 | 2-Butyl-1,3-Diazaspiro[4,4]Non-1-Ene-4-One | 138402-05-8 | Sparsentan |
| XSPA03 | 3-Amino-4,5-Dimethylisoxazole | 13999-39-8 | Sparsentan |
| XSPA04 | (2-(N-(4,5-Dimethylisoxazol-3-yl)-N-(Methoxymethyl)Sulfamoyl)Phenyl)Boronic Acid | 415697-58-4 | Sparsentan |
| XSUN01 | 5-Formyl-2,4-Dimethyl-1H-Pyrrole-3-Carboxylic Acid | 253870-02-9 | Sunitinib |
| XSUN02 | 5-Fluoro-2-Oxindole | 56341-41-4 | Sunitinib |
| XFC012 | 2-Amino-5-Methylbenzoic Acid | 2941-78-8 | Suvorexant |
| XSUV04 | Benzyl (5R)-5-Methyl-1,4-Diazepane-1-Carboxylate | 1001401-60-0 | Suvorexant |
| XSUV05 | 5-Methyl-2-(2H-1,2,3-Triazol-2-yl)Benzoic Acid | 956317-36-5 | Suvorexant |
| XTED01 | Benzyl (3-Fluoro-4-(6-(2-Methyl-2H-Tetrazol-5-yl)Pyridin-3-yl)Phenyl)CarbaMate | 1220910-89-3 | Tedizolid Phosphate |
| XTED02 | 3-Fluoro-4-[6-(2-Methyl-2H-Tetrazol-5-yl)-3-Pyridinyl]-Benzenamine | 1638760-07-2 | Tedizolid Phosphate |
| XTED03 | 5-(2-Fluoro-4-Nitrophenyl)-2-(2-Methyl-2H-Tetrazol-5-yl)-Pyridine | 2415109-68-9 | Tedizolid Phosphate |
| XTIC01 | (1R,2S)-2-(3,4-Difluorophenyl)Cyclopropanamine (2R)-Hydroxy(phenyl)Ethanoate | 376608-71-8 | Ticagrelor |
| XTIC02 | 2-((3aR,4S,6R,6aS)-6-Amino-2,2-Dimethyltetrahydro-3aH-Cyclopenta[d][1,3]Dioxol-4-Yloxy)Ethanol L-Tataric Acid | 376608-65-0 | Ticagrelor |
| XTIC03 | 4,6-Dichloro-2-Propylthiopyrimidine-5-Amine | 145783-15-9 | Ticagrelor |
| XTIC04 | (1R,2S)-Rel-2-(3,4-Difluorophenyl)Cyclopropanamine Hydrochloride | 1156491-10-9 | Ticagrelor |
| XTIN01 | 3-Thienylmalonic Acid | 21080-92-2 | Ticarcillin |
| XTIN02 | 2,2-Dimethyl-5-(3-Thienyl)-4,6-Dione-1,3-Dioxane | 61857-83-8 | Ticarcillin |
| XTOF02 | Cis-N-Benzyl-3-Methylamino-4-Methyl-Piperidine Bis-(Hydrochloride) | 1062580-52-2 | Tofacitinib Citrate |
| XTOF03 | Bis[(3R,4R)-1-Benzyl-N,4-Dimethylpiperidin-3-Amine]di-p-Toluyl-L-Tartrate | 477600-71-8 | Tofacitinib Citrate |
| XTOF05 | 2,4-Dichloro-7H-Pyrrolo[2,3-d]Pyrimidine | 90213-66-4 | Tofacitinib Citrate |
| XTOF07 | 4-Chloro-7-(4-Methylphenylsulfonyl)-7H-Pyrrolo[2,3-d]Pyrimidine | 479633-63-1 | Tofacitinib Citrate |
| XTOF09 | N-Methyl-N-[(3R,4R)-4-Methyl-1-(Phenylmethyl)-3-Piperidinyl]-7-[(4-Methylphenyl)Sulfonyl]-7H-Pyrrolo[2,3-d]Pyrimidin-4-Amine | 923036-30-0 | Tofacitinib Citrate |
| XVEN01 | Methyl 2-[(1H-Pyrrolo[2,3-b]Pyridin-5-Yl)Oxy]-4-Fluorobenzoate | 1235865-75-4 | Venetoclax |
| XVEN02 | 1-[[2-(4-Chlorophenyl)-4,4-Dimethylcyclohex-1-Enyl]Methyl]Piperazine | 1228780-72-0 | Venetoclax |
| XVEN03 | 3-Nitro-4-[[(Tetrahydropyran-4-yl)Methyl]Amino]Benzenesulfonamide | 1228779-96-1 | Venetoclax |
| XVEN04 | 1H-Pyrrolo[2,3-B]Pyridin-5-ol | 98549-88-3 | Venetoclax |
| XVEN05 | 1-((4’-chloro-5,5-dimethyl-3,4,5,6-tetrahydro-[1,1’-biphenyl]-2-yl)methyl)piperazinedihydrochloride | 1628047-87-9 | Venetoclax |
| XVEN06 | 4'-Chloro-5,5-Dimethyl-3,4,5,6-Tetrahydro-[1,1'-Biphenyl]-2-Carbaldehyde | 1228837-05-5 | Venetoclax |
| XVEN07 | (2-(4-Chlorophenyl)-4,4-Dimethylcyclohex-1-Enyl)Methanol | 1228780-51-5 | Venetoclax |
| XVIL01 | (2S)-1-(Chloroacetyl)-2-Pyrrolidinecarbonitrile | 207557-35-5 | Vildagliptin |
| XVON01 | 5-(2-Fluorophenyl)-1H-Pyrrole-3-Carboxaldehyde | 881674-56-2 | Vonoprazan Fumarate |
| XVON02 | 3-Pyridine Sulfonyl Chloride | 16133-25-8 | Vonoprazan Fumarate |
| XVON05 | 3-Pyridinesulfonic Acid | 636-73-7 | Vonoprazan Fumarate |
| XVRI01 | 3-(6-Chloro-5-Fluoropyrimidin-4-yl)-2-(2,4-Difluorophenyl)-1-(1H-1,2,4-Triazol-1-yl)Butan-2-ol Hydrochloride | 188416-20-8 | Voriconazole |
| XTOF01 | 2-(Trimethylsilyl)Ethoxymethyl Chloride | 76513-69-4 | Tofacitinib Citrate |
| XTOF04 | 4-Chloropyrrolo[2,3-d]Pyrimidine | 3680-69-1 | Ruxolitinib Phosphate |
